Clin2
NCT07706777Possibly a fitRecruiting

Testing a new drug for acute gout flares

Acute Gouty Arthritis

Treatments studied

Part of Bones, joints & muscles, Pain clinical trials.

This trial tests an oral medication (HRS-2129) to see if it can calm a sudden gout flare and reduce joint pain. It may help if you are currently having a moderate-to-severe gout attack and are otherwise in good health.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 2
Enrollment
90 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You have a current, sharp attack of gout (acute gout flare).
  • Your joint pain is at least 50 out of 100 on a pain scale.
  • You have no history of severe allergies (like to certain medicines).
  • You have not been treated for an irregular heartbeat or have other heart rhythm problems.
  • Your liver and kidney function are normal (checked by your doctor).
  • You do not have poorly controlled high blood pressure or nervous system/mental illness.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07145229Recruiting· Phase 2
Testing a new drug for acute gout flares

This trial tests a new medication, ABP-745, for people having an acute gout flare. It aims to see if the drug is safe and helps reduce pain and inflammation.

Peoria, Arizona
NCT07842497Not yet recruiting· Phase 2
New treatment for sudden gout attacks

This study tests a new medication for people with sudden gout flare-ups who haven't gotten relief from or can't take the usual treatments. It may help reduce pain and inflammation faster, and you'll receive either the study drug or a placebo (inactive treatment) along with standard care.

Jing’an, Shanghai Municipality
NCT07324434Enrolling by invitation· Phase 1
Study of an oral tablet for healthy adults and those with high uric acid

This trial tests a new tablet (F-02-2-Na) to see if it's safe and how the body processes it. It's for healthy volunteers and people with high uric acid levels who may need long-term treatment.

Guangzhou, Guangdong
NCT07498647Not yet recruiting· Phase 2
Testing a new tablet for gout and high uric acid

This trial tests an investigational tablet called BR2251 to see if it can lower uric acid levels in people with gout and hyperuricemia (too much uric acid in the blood). If you qualify, you may get a new treatment that could help prevent painful gout attacks.

NCT07708181Not yet recruiting· Phase 2
Study of a new medicine to prevent gout flares

This study tests a medicine called SSGJ-613 to see if it can reduce gout flares when people start treatment to lower uric acid. It may help people who have frequent gout attacks.

NCT05658575Recruiting· Phase 2/Phase 3
Tablets to treat sudden gout flare pain

This trial studies dapansutrile tablets (OLT1177) to see how well they work for people in the first 4 days of an acute gout flare. It may help reduce pain and inflammation in the specific joint where your gout is flaring.

Birmingham, Alabama

Hear when a new Acute Gouty Arthritis trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.